Get App
Last Updated : Nov 14, 2019 11:43 AM IST | Source:

Hold Sun Pharmaceutical Industries target of Rs 460: Sharekhan

Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated November 13, 2019.

Broker Research @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Sun Pharmaceutical Industries

Sun Pharma’s Q2FY2020 results are in line with estimates. Staggered penetration of specialty portfolio, higher specialty promotional spends, increasing R&D, and continued pricing issues in the U.S. are likely to be the key challenge for earnings growth We expect the company to report sales and profit CAGR of 14% and 22%, respectively, over the next two years.


We maintain Hold rating on Sun Pharma with a revised PT of Rs 460.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Nov 14, 2019 11:43 am
Follow us on